Role of CEACAM1 as a regulator of T cells

Annals of the New York Academy of Sciences

Volumn 1072, Issue , 2006, Pages 155-175

  Nagaishi, Takashi ^a   Iijima, Hideki ^a   Nakajima, Atsushi ^a   Chen, Daohong ^a   Blumberg, Richard S ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Inflammatory bowel disease; Inhibition; Receptors; T lymphocytes

Indexed keywords

CARCINOEMBRYONIC ANTIGEN RELATED CELL ADHESION MOLECULE 1;

BINDING SITE; COLITIS; CONFERENCE PAPER; CYTOKINE PRODUCTION; ENTERITIS; HUMAN; IMMUNE SYSTEM; INFLAMMATION; NONHUMAN; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

EID: 33749020847     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1326.004     Document Type: Conference Paper

References (83)

1. STROBER, W., I.J. FUSS & R.S. BLUMBERG. 2002. The immunology of mucosal models of inflammation. Annu. Rev. Immunol. 20: 495-549.
2. UHLIG, H.H. & F. POWRIE. 2005. The role of mucosal T lymphocytes in regulating intestinal inflammation. Springer Semin. Immunopathol. 27: 167-180.
3. VELAZQUEZ, P., B. WEI & J. BRAUN. 2005. Surveillance B lymphocytes and mucosal immunoregulation. Springer Semin. Immunopathol. 26: 453-462.
4. MIZOGUCHI, A., E. MIZOGUCHI, et al. 2002. Chronic intestinal inflammatory condition generates IL-10 producing regulatory B cell subset characterized by CD1d upregulation. Immunity 16: 219-230.
5. BRIMNES, J., M. ALLEZ, et al. 2005. Defects in CD8+ regulatory T cells in the lamina propria of patients with inflammatory bowel disease. J. Immunol. 174: 5814-5822.
6. KUNOS, G. & P. PACHER. 2004. Cannabinoids cool the intestine. Nat. Med. 10: 678-679.
7. FIORUCCI, S., J.L. WALLACE, et al. 2004. A beta-oxidation-resistant A4 analog treats hapten-induced colitis by attenuating inflammation and immune dysfunction. Proc. Natl. Acad. Sci. USA 101: 15736-15741.
8. MAKOTO, A., M. YOSHIDA, et al. 2005. Resolvin E1, an endogenous lipid mediator derived from omega-3 eicosapentaenoic acid, protects against 2,4,6-trinitrobenzene sulfonic acid-induced colitis. Proc. Natl. Acad. Sci. USA 102: 7671-7676.
9. VOWINKEL, T., M. MORI, et al. 2004. Apolipoprotein A-IV inhibits experimental colitis. J. Clin. Invest. 114: 260-269.
10. WADA, K., A. NAKAJIMA & R.S. BLUMBERG. 2001. PPAR-γ and inflammatory bowel disease: a new therapeutic target for ulcerative colitis and Crohn's disease. Trends Molec. Med. 7: 329-331
11. NAKAJIMA, A., K. WADA, H. MIKI, et al. 2001. Endogenous PPAR-γ mediates anti-inflammatory activity in murine ischemia-reperfusion injury. Gastroenterology 120: 460-469.
12. KEIR, M.E. & A.H. SHARPE. 2005. Th B7/CD28 costimulatory family in autoimmunity. Immunol. Rev. 204: 128-143.
13. VON BOEHMER, H. 2005. Mechanisms of suppression by suppressor T cells. Nat. Immunol. 6: 338-344.
14. GREENWALD, R.J., G.J. FREEMAN & A.H. SHARPE. 2005. The B7 family revisited. Annu. Rev. Immunol. 23: 515-548.
15. MCGAHA, T.L., B. SORRENTINO & J.V RAVETCH. 2005. Restoration of tolerance in lupus by targeted inhibitory receptor expression. Science 307: 590-593.
16. HSU, K.C. & B. DUPONT. 2005. Natural killer cell receptors: regulating innate immune responses to hematologic malignancy. Semin. Hematol. 42: 91-103.
17. TAYLOR, L.S., S.P. PAUL & D.W. MCVICAR. 2000. Paired inhibitory and activating receptor signals. Rev. Immunogenet. 2: 204-219.
18. NEEL, B.C., H.J. GU & L. PAO. 2003. The 'Shp'ing news: SH2 domain-containing tyrosine phosphatases in cell signaling. Trends Biochem. Science 28: 284-293.
19. BENCHIMOL, S. et al. 1989. Carcinoembryonic antigen, a human tumor marker, functions as an intercellular adhesion molecule. Cell 57: 327-334.
20. ROBITAILLE, J. et al. 1999. Comparison of expression patterns and cell adhesion properties of the mouse biliary glycoproteins Bbgp 1 and Bbgp2. Eur. J. Biochem. 264: 534-544.
21. OIKAWA, S. et al. 1991. A specific heterotypic cell adhesion activity between members of carcinoembryonic antigen family, W272 and NCA, is mediated by N-domains. J. Biol. Chem. 266: 7995-8001.
22. STERN, N. et al. 2005. Carcinoembryonic antigen (CEA) inhibits NK killing via interaction with CEA-related cell adhesion molecule 1. J. Immunol. 174: 6692-6701.
23. WAGENER, C. & S. ERGUN. 2000. Angiogenic properties of the carcinoembryonic antigen-related cell adhesion molecule 1. Exp. Cell. Res. 261: 19-24.
24. NAJJAR, S.M. 2002. Regulation of insulin action by CEACAMl. Trends Endocrinol. Metab. 13: 240-245.
25. ILANTZIS, C., L. DEMARTE, et al. 2002. Deregulated expression of the human tumor marker CEA and CEA family member CEACAM6 disrupts tissue architecture and blocks colonocyte differentiation. Neoplasia 4: 151-163.
26. KIRSHNER, J., C.J. CHEN, P. LIU, et al. 2003. CEACAM1-4S, a cell-cell adhesion molecule, mediates apoptosis and reverts mammary carcinoma cells to a normal morphogenic phenotype in a 3D culture. Proc. Natl. Acad. Sci. USA 100: 521-526.
27. FOURNES, B., S. SADEKOVA, C. TURBIDE, et al. 2001. The CEACAM1-L Ser503 residue is crucial for inhibition of colon cancer cell tumorigenicity. Oncogene 20: 219-230.
28. NITTKA, S., J. GUNTHER, C. EBISCH, et al. 2004. The human tumor suppressor CEACAM1 modulates apoptosis and is implicated in early colorectal tumorigenesis. Oncogene 23: 9306-9313.
29. GRAY-OWEN, S.D. 2003. Neisserial Opa proteins: impact on colonization, dissemination and immunity. Scand. J. Infect. Dis. 35: 614-618.
30. HEMMILA, E. et al. 2004. Ceacam1a-/- mice are completely resistant to infection by murine coronavirus mouse hepatitis virus a59. J. Virol. 78: 10156-10165.
31. ÖBRINK, B. 1997. CEA adhesion molecules: multifunctional proteins with signal-regulatory properties. Curr. Opin. Cell. Biol. 9: 616-626.
32. TAN, K. et al. 2002. Crystal structure of murine sCEACAM1a[1,4]: a coronavirus receptor in the CEA family. EMBO J. 21: 2076-2086.
33. BEAUCHEMIN, N., P. DRABER, G. DVEKSLER, et al. 1999. Nomenclature announcement: redefined nomenclature for members of the carcinoembryonic antigen family. Exp. Cell. Res. 252: 243-249.
34. SINGER, B.B., I. SCHEFFRAHN & B. ÖBRINK. 2000. The tumor growth-inhibiting cell adhesion molecule CEACAM1 (C-CAM) is differently expressed in proliferating and quiescent epithelial cells and regulates cell proliferation. Cancer Res. 60: 1236-1244.
35. EDLUND, M., I. BLIKSTAD & B. ÖBRINK. 1996. Calmodulin binds to specific sequences in the cytoplasmic domain of C-CAM and down-regulates C-CAM self-association. J. Biol. Chem. 271: 1393-1399.
36. CHOTHIA, C. & E.Y. JONES. 1997. The molecular structure of cell adhesion molecules. Annu. Rev. Biochem. 66: 823-862.
37. WATT, S.M. et al. 2001. Homophilic adhesion of human CEACAM1 involves N-terminal domain interactions: structural analysis of the binding site. Blood 98: 1469-1479.
38. MARKEL, G. et al. 2004. The critical role of residues 43R and 44Q of carcinoembryonic antigen cell adhesion molecules-1 in the protection from killing by human NK cells. J. Immunol. 173: 3732-3739.
39. MARKEL, G. et al. 2004. The mechanisms controlling NK cell autoreactivity in TAP2-deficient patients. Blood 103: 1770-1778.
40. MARKEL, G. et al. 2002. CD66A interactions between human melanoma and NK cells: a novel class 1 MHC-independent inhibitory mechanism of cytotoxicity. J. Immunol. 168: 2803-2810.
41. KAMMERER, R., D. STOBER, B.B. SINGER, et al. 2001. Carcinoembryonic antigen-related cell adhesion molecule 1 on murine dendritic cells is a potent regulation of T cell stimulation. J. Immunol. 166: 6537-6544.
42. COUTELIER, J.-P. et al. 1994. B lymphocyte and macrophage expression of carcinoembryonic antigen-related adhesion molecules that serve as receptors for murine coronavirus. Eur. J. Immunol. 24: 1383-1390.
43. GREICIUS, G., E. SEVERINSON, N. BEAUCHEMIN, et al. 2003. CEACAM1 is a potent regulator of B cell receptor complex-induced activation. J. Leukocyte Biol. 74: 126-134.
44. CHIEN, T. et al. 2001. Biliary glycoprotein (BGPa, CD66a, CEACAM1) mediates inhibitory signals. J. Leukocyte Biol. 70: 335-340.
45. NAKAJIMA, A. et al. 2002. Activation-induced expression of carcinoembryonic antigen-cell adhesion molecule 1 regulates mouse T lymphocyte function. J. Immunol. 168: 1028-1035.
46. MÖLLER, M.J., R. KAMMERER, et al. 1996. Biliary glycoprotein (BGP) expression on T cells and on a natural-killer-cell sub-population. Int. J. Cancer. 65: 740-745.
47. KAMMERER, R., S. HAHN, et al. 1998. Biliary glycoprotein (CD66a), a cell adhesion molecule of the immunoglobulin superfamily, on human lymphocytes: structure, expression and involvement in T cell activation. Eur. J. Immunol. 28: 3664-3674.
48. GUY-GRAND, D. & P. VASSALLI. 2002. Gut intraepithelial lymphocyte development. Curr. Opin. Immunol. 14: 255-259.
49. MORALES, V.M. et al. 1999. Regulation of human intestinal intraepithelial lymphocyte cytolytic function by biliary glycoprotein (CD66a). J. Immunol. 163: 1363-1370.
50. + lymphocytes. Nat. Immunol. 3: 229-236.
51. DONDA, A. et al. 2000. Locally inducible CD661 (CEACAM1) as an amplifier of the human intestinal T cell response. Eur. J. Immunol. 30: 2593-2603.
52. SINGER, B.B. et al. 2002. Carcinoembryonic antigen-related cell adhesion molecule 1 expression and signaling in human, mouse, and rat leukocytes: evidence for replacement of the short cytoplasmic domain isoform by glycosylphosphatidylinositol-linked proteins in human leukocytes. J. Immunol. 168: 5139-5146.
53. TANAKA, K., Y. HINODA, H. TAKAHASHI, et al. 1997. Decreased expression of biliary glycoprotein in hepatocellular carcinomas. Int. J. Cancer 20: 15-19.
54. Luo, W., C.G. WOOD, K. EARLEY, et al. 1997. Suppression of tumorigenicity of breast cancer cells by an epithelial cell adhesion molecule (C-CAMl): the adhesion and growth suppression are mediated by different domains. Oncogene 14: 1697-1704.
55. KUNATH, T., C. ORDOÑEZ-GARCIA, et al. 1995. Inhibition of colonic tumor cell growth by biliary glycoprotein. Oncogene 11: 2375-2382.
56. TURBIDE, C., T. KUNATH, et al. 1997. Optimal ratios of biliary glycoprotein isoforms required for inhibition of colonic tumor cell growth. Cancer Res. 57: 2781-2788.
57. HSIEH, J.-T. et al. 1995. Tumor suppressive role of an androgen-regulated epithelial cell adhesion molecule (C-CAM) in prostate carcinoma cell revealed by sense and antisense approaches. Cancer Res. 55: 190-197.
58. HUBER, M. et al. 1999. The carboxyl-terminal region of biliary glycoprotein controls its tyrosine phosphorylation and association with protein-tyrosine phosphatases SHP-1 and SHP-2 in epithelial cells. J. Biol. Chem. 274: 335-344.
59. c-src with biliary glycoprotein (CD66a), an adhesion molecule of the carcinoembryonic antigen family downregulated in colorectal carcinomas. Oncogene 11: 1649-1655.
60. IIJIMA, H. et al. 2004. Specific regulation of T helper cell 1-mediated murine colitis by CEACAM1. J. Exp. Med. 199: 471-482.
61. CHEN, C.-J. & J.E. SHIVELY. 2004. The cell-cell adhesion molecule carcinoembryonic antigen-related cellular adhesion molecule 1 inhibits IL-2 production and proliferation in human T cells by association with Src homology protein-1 and down-regulates IL-2 receptor. J. Immunol. 172: 3544-3552.
62. CHEN, D. et al. 2004. Carcinoembryonic antigen-related cellular adhesion molecule 1 isoforms alternatively inhibit and costimulate human T cell function. J. Immunol. 172: 3535-3543.
63. MARKEL, G. et al. 2002. Pivotal role of CEACAMl protein in the inhibition of activated decidual lymphocyte functions. J. Clin. Invest. 110: 943-953.
64. KIRSHNER, J., C.-J. CHEN, et al. 2003. CEACAM1-4S, a cell-cell adhesion molecule, mediates apoptosis and reverts mammary carcinoma cells to a normal morphogenic phenotype in a 3D culture. Proc. Natl. Acad. Sci. USA 100: 521-526.
65. VÉLY, F. & E. VIVIER. 1999. Conservation of structural features reveals the existence of a large family of inhibitory cell surface receptors and noninhibitory/activatory counterparts. J. Immunol. 159: 2075-2077.
66. HSU, K.C., S. CHIDA, et al. 2002. The killer cell immunoglobulin-like receptor (KIR) genomic region: gene-order, haplotypes and allelic polymorphism. Immunol. Rev. 190: 40-52.
67. WILLIAMS, W.K., GUI-S. JIANG & K.V HOLMES. 1991. Receptor for mouse hepatitis virus is a memberofthe carcinoembryonic antigen family of glycoproteins. Proc. Natl. Acad. Sci. USA 88: 5533-5536.
68. LATCHMAN, Y. et al. 2001. PD-L2 is a second ligand for PD-1 and inhibits T cell activation. Nat. Immunol. 2: 261-268.
69. GALLAGHER, T.M. 1997. A role for naturally occurring variation of the murine coronavirus spike protein in stabilizing association with the cellular receptor. J. Virol. 71: 3129-3137.
70. KAMINSKA, B. 2005. MAPK signalling pathways as molecular targets for anti-inflammatory therapy-from molecular mechanisms to therapeutic benefits. Biochim. Biophys. Acta 175: 253-262.
71. NEURATH, M.F., B. WEIGMANN, S. FINOTTO, et al. 2002. The transcription factor T-bet regulates mucosal T cell activation in experimental colitis and Crohn's disease. J. Exp. Med. 195: 1129-1143.
72. HELLER, F., I.J. FUSS, E.E. NIEUWENHUIS, et al. 2002. Oxazolonecolitis, a Th2 colitis model resembling ulcerative colitis, is mediated by IL-13-producing NK-T cells. Immunity 17: 629-638.
73. BRÜMMER, J. et al. The CD66 complex: activation of tyrosine kinases of the Src family. In VIth Leukocyte Culture Conference: CD66 Family Workshop.
74. BRADSHAW, J.D. et al. 1997. Interaction of the cyt tail of CTLA-4 CD152 with a clathrin-associated protein is negatively regulated by tyrosine phosphorylation. Biochemistry 36: 15975-15982.
75. ÖBRINK, B. et al. 2002. Computational analysis of isoform-specific signal regulation by CEACAM1: a cell adhesion molecule expressed in PC12 cells. Ann. N.Y. Acad. Sci. 971: 597-602.
76. OLSSON, H., K. WIKSTRÖM, et al. 1995. Cell adhesion activity of the short cytoplasmic domain isoform of C-CAM (C-CAM2) in CHO cells. FEBS Lett. 365: 51-56.
77. ++ independent cell adhesion activities of biliary glycoprotein, a member of carcinoembryonic antigen family, expressed on CHO cell surface. Biochem. Biophys. Res. Comm. 186: 881-887.
78. ABRAHAM, R.T. & A. WEISS. 2004. Jurkat T cells and development of the T-cell receptor signalling paradigm. Nat. Rev. Immunol. 4: 301-308.
79. SADEKOVA, S., N. LAMARCHE-VANE, et al. 2000. The CEACAM1-L glycoprotein associates with the actin cytoskeleton and localizes to cell-cell contact through activation of Rho-like GTPases. Molec. Biol. Cell. 11: 65-77.
80. FOURNÈS, B., J. FARRAH, M. OLSON, et al. 2003. Distinct Rho GTPase activities regulate epithelial cell localization of the adhesion molecule CEACAM1: involvement of the CEACAM1 transmembrane domain. Molec. Cell. Biol. 23: 7291-7304.
81. SCHUMANN, D., C.-J. CHEN, et al. 2001. Carcinoembryonic antigen cell adhesion molecule 1 directly associates with cytoskeleton proteins actin and tropomyosin. J. Biol. Chem. 276: 47421-47433.
82. VAN DER MERWE, P.A., S.J. DAVIS, et al. 2000. Cytoskeletal polarization and redistribution of cell-surface molecules during T cell antigen recognition. Semin. Immunol. 12: 5-21.
83. VEILLETTE, A., S. LATOUR & D. DAVIDSON. 2002. Negative regulation of immunoreceptor signaling. Annu. Rev. Immunol. 20: 669-707.